Try our beta test site
1171 studies found for:    "Slow Virus Diseases"
Show Display Options
Rank Status Study
1 Completed Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Lentivirus Infections;   Retroviridae Infections;   RNA Virus Infections;   Virus Diseases;   Sexually Transmitted Diseases, Viral;   Sexually Transmitted Diseases;   Immunologic Deficiency Syndromes;   Immune System Diseases;   Slow Virus Diseases
Interventions: Procedure: Circumcision;   Procedure: Flexible sigmoidoscopy
2 Unknown  Clinic-based ART Diagnostic Evaluation
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection;   RNA Virus Infections;   Virus Diseases
Intervention: Other: HIV-1 viral load testing
3 Completed
Has Results
Mesalamine to Reduce T Cell Activation in HIV Infection
Conditions: HIV Infections;   Sexually Transmitted Diseases;   Immune System Diseases;   Lentivirus Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Mesalamine (5-aminosalicylic acid, Apriso);   Drug: Placebo
4 Completed Being Responsible for Ourselves HIV Risk Reduction for Black MSM
Conditions: Human Immunodeficiency Virus Infection (HIV);   Sexually Transmitted Disease (STD)
Interventions: Behavioral: BRO HIV Risk Reduction Intervention;   Behavioral: Health Promotion Intervention
5 Completed Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men
Conditions: Human Immunodeficiency Virus Infection;   Sexually Transmitted Diseases
Interventions: Behavioral: Men Making a Difference HIV/STD Risk Reduction Intervention;   Behavioral: Health Promotion Control
6 Not yet recruiting A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Adult Women
Condition: HIV-1
Interventions: Biological: Ad26.Mos4.HIV;   Biological: Clade C gp140;   Biological: Placebo
7 Not yet recruiting Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2838232;   Drug: Cobicistat
8 Recruiting Safety and Therapeutic Efficacy of mAb VRC01 During ATI in Early Treatment During Acute HIV Infection
Condition: HIV
Interventions: Drug: VRC-HIVMAB01060-00-AB (VRC01);   Other: Sodium Chloride for Injection USP, 0.9%
9 Not yet recruiting Dolutegravir and Darunavir Evaluation in Adults Failing Therapy
Condition: HIV Infections
Interventions: Drug: N(t)RTIs;   Drug: Dolutegravir;   Drug: Darunavir;   Drug: Ritonavir
10 Not yet recruiting PH3b, DTG Study in HIV-1 Subjects Completing IMPAACT Study P1093
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir film-coated tablets;   Drug: Dolutegravir film-coated dispersible tablets
11 Active, not recruiting Biomarkers for Muscle Function and Aging in Chronic HIV Infection
Condition: HIV
Intervention:
12 Active, not recruiting Synbiotics in Advanced HIV Infection
Condition: HIV Infection Asymptomatic
Interventions: Dietary Supplement: PMT25341;   Dietary Supplement: Placebo
13 Enrolling by invitation An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 Study
Conditions: Hiv;   Human Immunodeficiency Virus
Intervention: Drug: PRO 140 SC injections
14 Not yet recruiting Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection
Condition: HIV Infection Primary
Intervention: Drug: Dolutegravir
15 Recruiting Expanding HIV Testing and Prevention to Reach Vulnerable Young Women
Conditions: Condomless Sex;   Human Immunodeficiency Virus (HIV);   Sexually Transmitted Infections (STIs);   Alcohol and Drug Use;   Violence and Victimization;   Access and Linkage to Healthcare;   Education Advancement
Interventions: Behavioral: Young Women's Health CoOp (YWHC);   Behavioral: Standard HTC
16 Not yet recruiting Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
Conditions: Human Papillomavirus;   Human Immunodeficiency Virus;   Hepatitis C;   ColoRectal Cancer
Interventions: Device: OraQuick Swab;   Device: Fecal Immunochemical Test;   Device: OraQuick Fingerstick;   Other: Standard Screening Tests
17 Enrolling by invitation Safe Generations Plus: Swaziland PMTCT LTF Study
Condition: HIV (Human Immunodeficiency Virus)
Intervention:
18 Recruiting NC Young Women's CoOperative (CoOp)
Conditions: Condomless Sex;   Human Immunodeficiency Virus (HIV);   Sexually Transmitted Infection (STI);   Linkage to Care;   Alcohol and Drug Use
Interventions: Behavioral: Face-to-Face Women's CoOperative (WC);   Behavioral: mHealth Women's CoOperative (WC);   Behavioral: HIV Counseling and Testing
19 Recruiting Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Cabotegravir (CAB) tablet;   Drug: Rilpivirine (RPV) tablet;   Drug: Cabotegravir - Injectable Suspension (CAB LA);   Drug: Rilpivirine - Injectable Suspension (RPV LA);   Drug: 2 NRTIs plus an INI, NNRTI, or PI
20 Recruiting Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Cabotegravir (CAB) tablet;   Drug: Rilpivirine (RPV) tablet;   Drug: Cabotegravir - Injectable Suspension (CAB LA);   Drug: Rilpivirine - Injectable Suspension (RPV LA);   Drug: ABC/DTG/3TC STR - Tablet;   Drug: DTG Tablet

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.